Medicine Description sigmazidim 1 gm
Sigmazidim 1 gm Vial is a medication that belongs to the third generation of cephalosporin antibiotics. Its bactericidal action is primarily directed against a range of gram-negative bacteria, including Pseudomonas aeruginosa. The mechanism involves the inhibition of bacterial cell wall synthesis through the binding to penicillin-binding proteins (PBPs). By binding to these proteins, ceftazidime disrupts the transpeptidation process, which is crucial for the cross-linking of peptidoglycan layers in the bacterial cell wall. This disruption leads to cell lysis and death of the bacteria, making ceftazidime particularly effective in treating infections caused by susceptible organisms.
Indications and Uses of Sigmazidim 1 gm Vial
- Febrile neutropenia in patients with hematological malignancies
- Infections in burn patients
- Respiratory tract infections
- Urinary tract infections
- Bone and joint infections
- Septicemia
- Skin and soft tissue infections
- Intra-abdominal infections
- Infections caused by Pseudomonas aeruginosa
Side Effects of Sigmazidim 1 gm Vial
- Nausea
- Vomiting
- Diarrhea
- Rash
- Allergic reactions
- Elevated liver enzymes
- Seizures (in cases of renal impairment)
- Superinfection with resistant organisms
Storage and Handling
Store Sigmazidim 1 gm Vial at controlled room temperature, away from direct sunlight and moisture. Once reconstituted, it should be used promptly or stored in the refrigerator and used within a specific time frame as indicated by the manufacturer.
Patient Advice and Precautions
Before administration, ensure to assess for any history of allergies to cephalosporins or penicillins. It is essential to monitor renal function during therapy, as dose adjustments may be necessary in patients with renal impairment. Counsel patients regarding the potential for gastrointestinal side effects and the importance of completing the full course of therapy to reduce the risk of resistance.